NR3C1 and acute lymphoblastic leukemia: A recent study by Liu et al., involving 333 newly diagnosed and 18 relapsed ALL cases, found NR3C1 mutations in 3 (0.9%) of the newly diagnosed patients and in 2 (11.1%) of the relapsed participants.